Vericel (VCEL) Operating Margin (QoQ) (2013 - 2026)

Vericel (VCEL) Operating Margin (QoQ) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Vericel 2.30 Bn 2.15 Bn 49.27 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -3,591.00
Dec 31, 2025 1,901.00
Sep 30, 2025 832.00
Jun 30, 2025 2,111.00
Mar 31, 2025 -4,884.00
Dec 31, 2024 2,877.00
Sep 30, 2024 720.00
Jun 30, 2024 -80.00
Mar 31, 2024 -3,024.00
Dec 31, 2023 3,068.00
Sep 30, 2023 189.00
Jun 30, 2023 695.00
Mar 31, 2023 -3,148.00
Dec 31, 2022 2,926.00
Sep 30, 2022 695.00
Jun 30, 2022 -438.00
Mar 31, 2022 -2,899.00
Dec 31, 2021 2,341.00
Sep 30, 2021 -528.00
Jun 30, 2021 39.00